CN105169263A - 一种用于慢性宫颈炎的清洗用中药 - Google Patents
一种用于慢性宫颈炎的清洗用中药 Download PDFInfo
- Publication number
- CN105169263A CN105169263A CN201510623938.3A CN201510623938A CN105169263A CN 105169263 A CN105169263 A CN 105169263A CN 201510623938 A CN201510623938 A CN 201510623938A CN 105169263 A CN105169263 A CN 105169263A
- Authority
- CN
- China
- Prior art keywords
- chinese medicine
- traditional chinese
- resina
- chronic cervicitis
- radix euphorbiae
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000003814 drug Substances 0.000 title claims abstract description 47
- 206010008323 cervicitis Diseases 0.000 title claims abstract description 14
- 201000003988 chronic cervicitis Diseases 0.000 title claims abstract description 12
- 238000011010 flushing procedure Methods 0.000 title abstract 4
- 241001646826 Isodon rubescens Species 0.000 claims abstract description 9
- QYZBCWXZSYTIOY-UHFFFAOYSA-N Mercuric oxide Chemical compound [O-2].[Hg+2] QYZBCWXZSYTIOY-UHFFFAOYSA-N 0.000 claims abstract description 9
- 241001103621 Psychotria Species 0.000 claims abstract description 9
- 210000000582 semen Anatomy 0.000 claims description 9
- 241000628997 Flos Species 0.000 claims description 8
- 239000009286 sanguis draxonis Substances 0.000 claims description 8
- 238000004140 cleaning Methods 0.000 claims description 7
- 238000001816 cooling Methods 0.000 claims description 5
- 230000000694 effects Effects 0.000 abstract description 11
- 208000024891 symptom Diseases 0.000 abstract description 5
- 238000004519 manufacturing process Methods 0.000 abstract description 4
- 238000002360 preparation method Methods 0.000 abstract description 4
- 206010061218 Inflammation Diseases 0.000 abstract description 3
- 235000013399 edible fruits Nutrition 0.000 abstract description 3
- 230000004054 inflammatory process Effects 0.000 abstract description 3
- 230000003467 diminishing effect Effects 0.000 abstract description 2
- 230000001954 sterilising effect Effects 0.000 abstract description 2
- 238000004659 sterilization and disinfection Methods 0.000 abstract description 2
- 241000759909 Camptotheca Species 0.000 abstract 1
- 244000146462 Centella asiatica Species 0.000 abstract 1
- 235000004032 Centella asiatica Nutrition 0.000 abstract 1
- 235000014375 Curcuma Nutrition 0.000 abstract 1
- 244000164480 Curcuma aromatica Species 0.000 abstract 1
- 241001532027 Hosta ventricosa Species 0.000 abstract 1
- 244000018716 Impatiens biflora Species 0.000 abstract 1
- 235000015912 Impatiens biflora Nutrition 0.000 abstract 1
- 241001079002 Melicope pteleifolia Species 0.000 abstract 1
- 240000003109 Persicaria chinensis Species 0.000 abstract 1
- 240000002396 Rhinacanthus nasutus Species 0.000 abstract 1
- 241000913745 Spatholobus Species 0.000 abstract 1
- 235000005155 Tanacetum balsamita Nutrition 0.000 abstract 1
- 230000036592 analgesia Effects 0.000 abstract 1
- 230000009286 beneficial effect Effects 0.000 abstract 1
- 229940105847 calamine Drugs 0.000 abstract 1
- VFLDPWHFBUODDF-FCXRPNKRSA-N curcumin Chemical compound C1=C(O)C(OC)=CC(\C=C\C(=O)CC(=O)\C=C\C=2C=C(OC)C(O)=CC=2)=C1 VFLDPWHFBUODDF-FCXRPNKRSA-N 0.000 abstract 1
- 229910052864 hemimorphite Inorganic materials 0.000 abstract 1
- 230000007794 irritation Effects 0.000 abstract 1
- 239000004922 lacquer Substances 0.000 abstract 1
- 235000014692 zinc oxide Nutrition 0.000 abstract 1
- 239000011787 zinc oxide Substances 0.000 abstract 1
- CPYIZQLXMGRKSW-UHFFFAOYSA-N zinc;iron(3+);oxygen(2-) Chemical compound [O-2].[O-2].[O-2].[O-2].[Fe+3].[Fe+3].[Zn+2] CPYIZQLXMGRKSW-UHFFFAOYSA-N 0.000 abstract 1
- 230000001737 promoting effect Effects 0.000 description 22
- 239000008280 blood Substances 0.000 description 18
- 210000004369 blood Anatomy 0.000 description 18
- 208000002193 Pain Diseases 0.000 description 17
- 210000004185 liver Anatomy 0.000 description 16
- 230000017531 blood circulation Effects 0.000 description 15
- 231100000614 poison Toxicity 0.000 description 14
- 239000003440 toxic substance Substances 0.000 description 13
- 229940079593 drug Drugs 0.000 description 11
- 210000000952 spleen Anatomy 0.000 description 11
- 208000014674 injury Diseases 0.000 description 9
- 210000004072 lung Anatomy 0.000 description 9
- 230000008736 traumatic injury Effects 0.000 description 8
- 230000008961 swelling Effects 0.000 description 7
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 7
- 230000000202 analgesic effect Effects 0.000 description 6
- 235000009508 confectionery Nutrition 0.000 description 6
- 208000001848 dysentery Diseases 0.000 description 6
- 239000002994 raw material Substances 0.000 description 6
- 241000475481 Nebula Species 0.000 description 5
- 208000025747 Rheumatic disease Diseases 0.000 description 5
- VSJKWCGYPAHWDS-FQEVSTJZSA-N camptothecin Chemical compound C1=CC=C2C=C(CN3C4=CC5=C(C3=O)COC(=O)[C@]5(O)CC)C4=NC2=C1 VSJKWCGYPAHWDS-FQEVSTJZSA-N 0.000 description 5
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 5
- 210000003734 kidney Anatomy 0.000 description 5
- 230000000552 rheumatic effect Effects 0.000 description 5
- 210000002784 stomach Anatomy 0.000 description 5
- 230000017423 tissue regeneration Effects 0.000 description 5
- 201000000736 Amenorrhea Diseases 0.000 description 4
- 206010001928 Amenorrhoea Diseases 0.000 description 4
- 201000004624 Dermatitis Diseases 0.000 description 4
- 206010023126 Jaundice Diseases 0.000 description 4
- 208000003251 Pruritus Diseases 0.000 description 4
- 208000025865 Ulcer Diseases 0.000 description 4
- 210000001015 abdomen Anatomy 0.000 description 4
- 231100000540 amenorrhea Toxicity 0.000 description 4
- 230000001754 anti-pyretic effect Effects 0.000 description 4
- 239000002221 antipyretic Substances 0.000 description 4
- 230000004087 circulation Effects 0.000 description 4
- 201000010099 disease Diseases 0.000 description 4
- 235000013305 food Nutrition 0.000 description 4
- 244000045947 parasite Species 0.000 description 4
- 230000001225 therapeutic effect Effects 0.000 description 4
- 239000003053 toxin Substances 0.000 description 4
- 231100000765 toxin Toxicity 0.000 description 4
- 231100000397 ulcer Toxicity 0.000 description 4
- 206010000087 Abdominal pain upper Diseases 0.000 description 3
- 208000006820 Arthralgia Diseases 0.000 description 3
- 206010007247 Carbuncle Diseases 0.000 description 3
- 208000004880 Polyuria Diseases 0.000 description 3
- 206010053476 Traumatic haemorrhage Diseases 0.000 description 3
- 230000003110 anti-inflammatory effect Effects 0.000 description 3
- 230000001139 anti-pruritic effect Effects 0.000 description 3
- 239000003908 antipruritic agent Substances 0.000 description 3
- 208000010668 atopic eczema Diseases 0.000 description 3
- 206010013023 diphtheria Diseases 0.000 description 3
- 230000035619 diuresis Effects 0.000 description 3
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 3
- 238000005469 granulation Methods 0.000 description 3
- 230000003179 granulation Effects 0.000 description 3
- 239000011505 plaster Substances 0.000 description 3
- 239000000843 powder Substances 0.000 description 3
- 235000014347 soups Nutrition 0.000 description 3
- 238000012360 testing method Methods 0.000 description 3
- 239000002435 venom Substances 0.000 description 3
- 231100000611 venom Toxicity 0.000 description 3
- 210000001048 venom Anatomy 0.000 description 3
- HAWSQZCWOQZXHI-FQEVSTJZSA-N 10-Hydroxycamptothecin Chemical compound C1=C(O)C=C2C=C(CN3C4=CC5=C(C3=O)COC(=O)[C@]5(O)CC)C4=NC2=C1 HAWSQZCWOQZXHI-FQEVSTJZSA-N 0.000 description 2
- 241000894006 Bacteria Species 0.000 description 2
- 206010068402 Cervix inflammation Diseases 0.000 description 2
- 206010011224 Cough Diseases 0.000 description 2
- 206010012735 Diarrhoea Diseases 0.000 description 2
- 208000005171 Dysmenorrhea Diseases 0.000 description 2
- 206010013935 Dysmenorrhoea Diseases 0.000 description 2
- 206010017553 Furuncle Diseases 0.000 description 2
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 2
- 206010028116 Mucosal inflammation Diseases 0.000 description 2
- 206010028980 Neoplasm Diseases 0.000 description 2
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 2
- 206010040943 Skin Ulcer Diseases 0.000 description 2
- 208000002474 Tinea Diseases 0.000 description 2
- 208000006374 Uterine Cervicitis Diseases 0.000 description 2
- 208000027418 Wounds and injury Diseases 0.000 description 2
- 208000019790 abdominal distention Diseases 0.000 description 2
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 2
- 229910052782 aluminium Inorganic materials 0.000 description 2
- 230000000259 anti-tumor effect Effects 0.000 description 2
- 230000036528 appetite Effects 0.000 description 2
- 235000019789 appetite Nutrition 0.000 description 2
- 230000001684 chronic effect Effects 0.000 description 2
- 239000006071 cream Substances 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 230000007812 deficiency Effects 0.000 description 2
- 230000003203 everyday effect Effects 0.000 description 2
- 239000000284 extract Substances 0.000 description 2
- 208000035861 hematochezia Diseases 0.000 description 2
- 210000003026 hypopharynx Anatomy 0.000 description 2
- 230000007803 itching Effects 0.000 description 2
- 210000003141 lower extremity Anatomy 0.000 description 2
- 201000007227 lymph node tuberculosis Diseases 0.000 description 2
- 239000011777 magnesium Substances 0.000 description 2
- 229910052749 magnesium Inorganic materials 0.000 description 2
- 208000004396 mastitis Diseases 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 231100000957 no side effect Toxicity 0.000 description 2
- 239000002674 ointment Substances 0.000 description 2
- 230000001717 pathogenic effect Effects 0.000 description 2
- 229910052708 sodium Inorganic materials 0.000 description 2
- 239000011734 sodium Substances 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- 238000002560 therapeutic procedure Methods 0.000 description 2
- 206010044008 tonsillitis Diseases 0.000 description 2
- LAOOXBLMIJHMFO-UHFFFAOYSA-N 1-[2-(diethylamino)ethylamino]-4-methylthioxanthen-9-one;hydron;chloride Chemical compound Cl.S1C2=CC=CC=C2C(=O)C2=C1C(C)=CC=C2NCCN(CC)CC LAOOXBLMIJHMFO-UHFFFAOYSA-N 0.000 description 1
- 206010000077 Abdominal mass Diseases 0.000 description 1
- 206010063409 Acarodermatitis Diseases 0.000 description 1
- 208000008316 Arsenic Poisoning Diseases 0.000 description 1
- 206010005003 Bladder cancer Diseases 0.000 description 1
- 206010005913 Body tinea Diseases 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 244000025254 Cannabis sativa Species 0.000 description 1
- 201000009030 Carcinoma Diseases 0.000 description 1
- 208000002177 Cataract Diseases 0.000 description 1
- 206010010071 Coma Diseases 0.000 description 1
- 206010010741 Conjunctivitis Diseases 0.000 description 1
- 206010066968 Corneal leukoma Diseases 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 241000792859 Enema Species 0.000 description 1
- 241000588724 Escherichia coli Species 0.000 description 1
- 206010016717 Fistula Diseases 0.000 description 1
- 208000034507 Haematemesis Diseases 0.000 description 1
- 208000000616 Hemoptysis Diseases 0.000 description 1
- 208000032843 Hemorrhage Diseases 0.000 description 1
- 208000009889 Herpes Simplex Diseases 0.000 description 1
- 206010020741 Hyperpyrexia Diseases 0.000 description 1
- 208000004044 Hypesthesia Diseases 0.000 description 1
- 206010021531 Impetigo Diseases 0.000 description 1
- 206010061245 Internal injury Diseases 0.000 description 1
- PWHULOQIROXLJO-UHFFFAOYSA-N Manganese Chemical compound [Mn] PWHULOQIROXLJO-UHFFFAOYSA-N 0.000 description 1
- 208000019255 Menstrual disease Diseases 0.000 description 1
- 206010027514 Metrorrhagia Diseases 0.000 description 1
- 201000010927 Mucositis Diseases 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- 206010033078 Otitis media Diseases 0.000 description 1
- 206010033799 Paralysis Diseases 0.000 description 1
- 208000037062 Polyps Diseases 0.000 description 1
- 206010037660 Pyrexia Diseases 0.000 description 1
- 241000447727 Scabies Species 0.000 description 1
- XUIMIQQOPSSXEZ-UHFFFAOYSA-N Silicon Chemical compound [Si] XUIMIQQOPSSXEZ-UHFFFAOYSA-N 0.000 description 1
- 206010067868 Skin mass Diseases 0.000 description 1
- 241000191940 Staphylococcus Species 0.000 description 1
- 241000191967 Staphylococcus aureus Species 0.000 description 1
- 208000005718 Stomach Neoplasms Diseases 0.000 description 1
- 206010042674 Swelling Diseases 0.000 description 1
- 241000130764 Tinea Species 0.000 description 1
- RTAQQCXQSZGOHL-UHFFFAOYSA-N Titanium Chemical compound [Ti] RTAQQCXQSZGOHL-UHFFFAOYSA-N 0.000 description 1
- 208000007097 Urinary Bladder Neoplasms Diseases 0.000 description 1
- 206010046914 Vaginal infection Diseases 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 206010052428 Wound Diseases 0.000 description 1
- FMRLDPWIRHBCCC-UHFFFAOYSA-L Zinc carbonate Chemical compound [Zn+2].[O-]C([O-])=O FMRLDPWIRHBCCC-UHFFFAOYSA-L 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 201000010442 acute cervicitis Diseases 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000001093 anti-cancer Effects 0.000 description 1
- 230000001142 anti-diarrhea Effects 0.000 description 1
- 230000000843 anti-fungal effect Effects 0.000 description 1
- 230000002924 anti-infective effect Effects 0.000 description 1
- 229940121375 antifungal agent Drugs 0.000 description 1
- 210000000941 bile Anatomy 0.000 description 1
- 235000019636 bitter flavor Nutrition 0.000 description 1
- 230000000740 bleeding effect Effects 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 210000000481 breast Anatomy 0.000 description 1
- 238000009395 breeding Methods 0.000 description 1
- 230000001488 breeding effect Effects 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 210000000038 chest Anatomy 0.000 description 1
- 208000019902 chronic diarrheal disease Diseases 0.000 description 1
- 210000000795 conjunctiva Anatomy 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- ORMNPSYMZOGSSV-UHFFFAOYSA-N dinitrooxymercury Chemical compound [Hg+2].[O-][N+]([O-])=O.[O-][N+]([O-])=O ORMNPSYMZOGSSV-UHFFFAOYSA-N 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 239000007920 enema Substances 0.000 description 1
- 229940095399 enema Drugs 0.000 description 1
- 206010015037 epilepsy Diseases 0.000 description 1
- 210000000981 epithelium Anatomy 0.000 description 1
- 230000029142 excretion Effects 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 239000003889 eye drop Substances 0.000 description 1
- 229940012356 eye drops Drugs 0.000 description 1
- 210000002950 fibroblast Anatomy 0.000 description 1
- 230000003890 fistula Effects 0.000 description 1
- 230000000855 fungicidal effect Effects 0.000 description 1
- 210000000232 gallbladder Anatomy 0.000 description 1
- 206010017758 gastric cancer Diseases 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 210000001126 granulation tissue Anatomy 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 208000014617 hemorrhoid Diseases 0.000 description 1
- 230000023597 hemostasis Effects 0.000 description 1
- 206010019847 hepatosplenomegaly Diseases 0.000 description 1
- 208000034783 hypoesthesia Diseases 0.000 description 1
- 230000036737 immune function Effects 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 210000002429 large intestine Anatomy 0.000 description 1
- 210000000867 larynx Anatomy 0.000 description 1
- 239000011133 lead Substances 0.000 description 1
- 208000032839 leukemia Diseases 0.000 description 1
- 239000006210 lotion Substances 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 230000003211 malignant effect Effects 0.000 description 1
- 229910052748 manganese Inorganic materials 0.000 description 1
- 239000011572 manganese Substances 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- 239000012567 medical material Substances 0.000 description 1
- 230000003821 menstrual periods Effects 0.000 description 1
- 230000005906 menstruation Effects 0.000 description 1
- 229910000474 mercury oxide Inorganic materials 0.000 description 1
- UKWHYYKOEPRTIC-UHFFFAOYSA-N mercury(ii) oxide Chemical compound [Hg]=O UKWHYYKOEPRTIC-UHFFFAOYSA-N 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 230000001338 necrotic effect Effects 0.000 description 1
- 231100000862 numbness Toxicity 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 239000002574 poison Substances 0.000 description 1
- 230000007096 poisonous effect Effects 0.000 description 1
- 230000003389 potentiating effect Effects 0.000 description 1
- 230000035935 pregnancy Effects 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 230000035755 proliferation Effects 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 208000008128 pulmonary tuberculosis Diseases 0.000 description 1
- 208000005687 scabies Diseases 0.000 description 1
- 230000001843 schistosomicidal effect Effects 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 229910052710 silicon Inorganic materials 0.000 description 1
- 239000010703 silicon Substances 0.000 description 1
- 210000005125 simple columnar epithelium Anatomy 0.000 description 1
- 231100000019 skin ulcer Toxicity 0.000 description 1
- 201000011549 stomach cancer Diseases 0.000 description 1
- 208000006379 syphilis Diseases 0.000 description 1
- 201000003875 tinea corporis Diseases 0.000 description 1
- 229910052719 titanium Inorganic materials 0.000 description 1
- 239000010936 titanium Substances 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 231100000167 toxic agent Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 241001529453 unidentified herpesvirus Species 0.000 description 1
- 201000005112 urinary bladder cancer Diseases 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 210000001215 vagina Anatomy 0.000 description 1
- 235000015112 vegetable and seed oil Nutrition 0.000 description 1
- 239000008158 vegetable oil Substances 0.000 description 1
- 231100000925 very toxic Toxicity 0.000 description 1
- 238000010792 warming Methods 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 230000029663 wound healing Effects 0.000 description 1
- 229910000010 zinc carbonate Inorganic materials 0.000 description 1
- 235000004416 zinc carbonate Nutrition 0.000 description 1
- 239000011667 zinc carbonate Substances 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
本发明涉及中药应用领域,特别公开了一种用于慢性宫颈炎的清洗用中药。该用于慢性宫颈炎的清洗用中药由三丫苦,椿皮,火炭母,积雪草,狼毒,白鹤灵芝,血竭,山大颜,紫玉簪,鸡血藤,三棱,干漆,水红花子,喜树果,急性子,郁金,冬凌草,片姜黄,红粉,炉甘石和枫香脂为原料,按照一定的重量配比混合配制煎制而成。本发明配制简单,刺激性小,杀菌、消炎、镇痛效果显著,无副作用,安全性高,生产成本低,药效持续时间长,有利于病患及时减轻病状。
Description
(一)技术领域
本发明涉及中药应用领域,特别涉及一种用于慢性宫颈炎的清洗用中药。
(二)背景技术
宫颈炎是妇科常见疾病之一,包括子宫颈阴道部炎症及子宫颈管黏膜炎症。因子宫颈管阴道部鳞状上皮与阴道鳞状相延续,阴道炎症均可引起子宫颈阴道部炎症。由于子宫颈管黏膜上皮为单层柱状上皮,抗感染能力较差,易发生感染。临床多见的子宫颈炎是急性子宫颈管黏膜炎,若急性子宫颈炎未经及时诊治或病原体持续存在,可导致慢性子宫颈炎症。
现有技术中此类病症均使用西药治疗,治疗时间长,易反复,疗效差,增加了患者的治疗费用,给患者健康恢复带来诸多的不便。
(三)发明内容
本发明为了弥补现有技术的不足,提供了一种制备简单、疗效显著的用于慢性宫颈炎的清洗用中药。
本发明是通过如下技术方案实现的:
一种用于慢性宫颈炎的清洗用中药,由以下重量份数的中药制成:
三丫苦11~15g,椿皮10~16g,火炭母9~12g,积雪草9~16g,狼毒9~15g,白鹤灵芝10~16g,血竭9~16g,山大颜12~18g,紫玉簪10~19g,鸡血藤12~19g,三棱10~15g,干漆10~16g,水红花子12~19g,喜树果9~16g,急性子11~19g,郁金13~19g,冬凌草11~16g,片姜黄10~15g,红粉10~16g,炉甘石9~15g,枫香脂9~16g。
其优选的各原料的重量配比为:
三丫苦11g,椿皮10g,火炭母9g,积雪草9g,狼毒9g,白鹤灵芝10g,血竭9g,山大颜12g,紫玉簪10g,鸡血藤12g,三棱10g,干漆10g,水红花子12g,喜树果9g,急性子11g,郁金13g,冬凌草11g,片姜黄10g,红粉10g,炉甘石9g,枫香脂9g。
本发明所述中药加水以常规方式煎为药剂,冷却后以2500毫升为一剂封袋装存。
本发明配制简单,刺激性小,杀菌、消炎、镇痛效果显著,无副作用,安全性高,生产成本低,药效持续时间长,有利于病患及时减轻病状。
各原料的药用性能如下所示:
三丫苦:性寒,味苦。归肝经、肺经、胃经。清热解毒、行气止痛、燥湿止痒。属清热药下分类的清热燥湿药。用治热病高热不退、咽喉肿痛、热毒疮肿、风湿痹痛、湿火骨痛、毒蛇咬伤、胃热痛、跌打肿痛。外用治肤湿热疮、皮肤瘙痒、痔疮。
椿皮:性寒,味苦、涩。归大肠经、胃经、肝经。清热燥湿、收涩止带、止泻、止血。属清热药下属分类的清热燥湿药。用治赤白带下、湿热泻痢、久泻久痢、便血、崩漏。
火炭母:性微寒,味微酸、涩。归肝经、脾经。清热利湿、凉血解毒、明目退翳。属清热药下分类的清热燥湿药。外用:捣敷或煎水洗。用治暑湿泄泻、赤白痢疾,对慢性泻痢,亦可煎汁作保留灌肠;小儿夏季热、食少腹胀、湿热黄疸、肺热咳嗽、咽喉肿痛及白喉等症,乳痈、疖肿,以鲜品捣烂敷患处,并煎汤内服;皮炎、湿疹、脓疱疮,均用本品煎水外洗;角膜云翳、斑翳,对非中心性角膜白斑以及外眼炎症可制成眼药水滴眼。
积雪草:性寒,味苦、辛。归肝经、脾经、肾经。清湿热、解毒消肿、活血利尿。属清热药下分类的清热燥湿药。用治湿热黄疸、痈疮肿毒、跌打损伤、解砒霜中毒及蕈中毒、解暑。
狼毒:性平,味辛。归肝经、脾经。散结,杀虫。属杀虫止痒药。外用:适量,研粉或制成软膏,搽、敷。内服:煎汤,炮制后用1~2.4克,或入丸、散。外用于淋巴结结核、皮癣,灭蛆。具有抗肿瘤、杀蛆、灭孑孓等作用。
白鹤灵芝:味甘、淡,性平。归肺经。清肺止咳、利湿止痒。属杀虫止痒药,具抗真菌、病毒作用。用治肺结核早期。外用治体癣、湿疹。
血竭:性平,味甘、咸。归心经、肝经。祛瘀定痛、止血生肌。属拔毒生肌药。外用研末撒或人膏药用。用治跌打损伤、内伤瘀痛、外伤出血不止。临床用治妇女月经过多、痛经、咳血、便血。
山大颜:味苦,性凉。清热解毒、消肿拔毒。属拔毒生肌药,根、叶:白喉,扁桃体炎,咽喉炎,痢疾,肠伤寒,胃痛,风湿骨痛;叶:外用治跌打肿痛,外伤出血,毒蛇咬伤,疮疡肿毒,下肢溃疡。用治白喉、扁桃体炎、咽喉炎、痢疾、肠伤寒、胃痛、风湿骨痛。外用治跌打肿痛、外伤出血、毒蛇咬伤、疮疡肿毒、下肢溃疡。
紫玉簪:性平,味甘,有毒。归肺经、肾经。拔脓解毒,生肌。主治乳痈、疮痈肿毒;鲜草捣汁滴耳治中耳炎;将叶浸入菜油中数天,敷贴患外,每日换药1次,治小腿慢性溃疡。
鸡血藤:性温,味苦、甘。归肝经、肾经。补血、活血、通络,具抗炎作用。属活血化瘀药下分类的活血调经药。用治月经不调、血虚萎黄、麻木瘫痪、风湿痹痛。
三棱:性平,味辛、苦。归肝经、脾经。破血行气、消积止痛。属活血化瘀药下分类的破血消癥药。治疗癥瘕痞块、瘀血经闭、食积胀痛。
干漆:性温,味辛。归肝经、脾经。破瘀血、消积、杀虫。属活血化瘀药下分类的活血调经药。
水红花子:性微寒,味咸。归肝经、胃经。消瘀破积、健脾利湿、全身止痛。属活血化瘀药下分类的破血消癥药。治疗胁腹征积、水臌、胃疼、食少腹胀、火眼、疮肿、瘰疬。煎汤内服,外用适量,熬膏敷患处。
喜树果:性寒,味苦、涩。归脾经、胃经、肝经。抗癌,散结,破血化瘀。属活血化瘀药下分类的破血消癥药。主治各种肿瘤,·用于原发性肝癌,对胃癌、头颈部腺源性皮癌、白血病、膀胱癌等恶性肿瘤等。也用于治疗血吸虫病引起的肝脾肿大。抗肿瘤;有抑制成纤维细胞增生作用;抗早孕;抑制疱疹病毒。过去多从根中提取喜树碱,近年来研究发现果实疗效最佳,毒性小,喜树碱和羟基喜树碱含量最高,采集方便,又不损伤植株,故目前商品多收购果实,作为提取分离喜树碱和羟基喜树碱的原料。目前多用喜树果的提取物制成酒浸膏注射液及水煎膏片剂使用,其疗效与喜树碱纯品相似,而副作用明显低于喜树碱纯品。
急性子:性温,味微苦、辛。归肺经、肝经破血软坚、消积。属活血化瘀药下属分类的破血消癥药。治疗瘕痞块、经闭、噎膈。外用研末吹喉、点牙,调敷或熬膏贴。
郁金:性寒,味辛、苦。归肝、心、肺经。活血止痛、行气化疥、清心解郁、利胆退黄。属活血化瘀药下属分类的活血止痛药。用治经闭痛经、热病神昏、癫痫发狂、黄疸尿赤、胸腹胀痛、刺痛。
冬凌草:性微寒,味苦、甘。归肺经、胃经、肝经。清热解毒,活血止痛。属活血化瘀药下属分类的活血止痛药。属活血化瘀药下属分类的活血止痛药。
片姜黄:性温,味辛、苦。归脾经、肝经。破血行气、通经止痛。属活血化瘀药下属分类活血调经药。用治血滞经闭、行经腹痛、胸胁刺痛、风湿痹痛、肩臂疼痛,跌打损伤。有镇痛作用,可促进胆汁的分泌和排泄,对肝脏损伤有保护作用,能提高免疫功能等。
红粉:性热,味辛。有大毒。归肺经、脾经。拔毒、除脓、去腐、生肌。属拔毒生肌药。用治痈疽疔疮、梅毒下疳、一切恶疮、肉暗紫黑、腐肉不去、窦道瘘管、脓水淋漓、久不收口。主含粗氧化汞,另含硝酸汞及钠、镁、铝、铁等元素。外用可促进伤口愈合;在体外对金黄色葡萄球菌、大肠杆菌等常见化脓性细菌有很强的杀菌作用,其杀菌效力比石炭酸大100倍以上。
炉甘石:性平,味甘。归肝经、脾经。解毒、明目退翳、收湿止痒、敛疮。属拔毒生肌药。仅可外用,使用时研成细粉,适量调敷患处或点眼。用治目赤翳障、目缘赤烂、翳膜胬肉、溃疡不敛、脓水淋漓、湿疮、皮肤瘙痒。主含碳酸锌,此外尚含有多量的铁、铝、钙、镁、钠、硅,少量的铅、钛、锰等。用于治疗皮肤炎症或表面创伤,既可部分溶解、吸牧创面的分泌液而收敛,又能驱杀局部葡萄球菌和限制其繁殖,有较好的消炎止痛作用。
枫香脂:性平,味辛、微苦。归肺经、脾经。活血止痛、解毒、生肌、凉血。属拔毒生肌药。用治跌打损伤、痈疽肿痛、吐血、外伤出血等。
本发明以清热利湿、止带、排毒祛瘀、抑菌消炎、滋阴补肾为治则,多种药材组合协同,主要用于温肾壮阳、利湿止痒、养阴润燥、润肺生津,对慢性宫颈炎有显著的治疗作用。
临床观察:
(1)临床资料
本发明人于2003年至今,对453例慢性宫颈炎患者进行临床观察治疗。
(2)治疗方法
将制得的药剂加温后冲洗患处,每日二到三次。根据患者病情轻重计算治疗时间,轻度患者用5~7天左右,重病患者连用10~15天即可痊愈。
(3)疗效判定标准
疗效标准参照《中医病症判断疗效标准》中有关疗效标准。
治愈:临床症状全部消失,实验室检查正常。
显效:临床症状基本消失,试验室检查各相关指标接近正常水平。
有效:临床症状减轻,试验室检查各相关指标有所改善,体征有改善。
无效:临床症状无明显好转或加重。
(4)临床结果
临床治愈370例(81.68%),显效59例(13.02%),有效21例(4.64%),无效3例(0.66%),总有效率为99.34%。
本发明配制简单,吸收效果好,药效持续时间长,疗效显著,无副作用,安全性高,生产成本低,有利于病患及时减轻病状。
(四)具体实施方式
实施例1:
取三丫苦11g,椿皮10g,火炭母9g,积雪草9g,狼毒9g,白鹤灵芝10g,血竭9g,山大颜12g,紫玉簪10g,鸡血藤12g,三棱10g,干漆10g,水红花子12g,喜树果9g,急性子11g,郁金13g,冬凌草11g,片姜黄10g,红粉10g,炉甘石9g,枫香脂9g,将上述原料清洗干净,加水以常规方式煎为药剂,冷却后以2500毫升为一剂封袋装存。
用法用量:换药前使用本发明的水剂反复冲洗,清洁患处。
实施例2:
取三丫苦13g,椿皮12g,火炭母10g,积雪草13g,狼毒12g,白鹤灵芝12g,血竭21g,山大颜15g,紫玉簪15g,鸡血藤15g,三棱12g,干漆12g,水红花子15g,喜树果12g,急性子15g,郁金15g,冬凌草13g,片姜黄12g,红粉12g,炉甘石12g,枫香脂13g,将上述原料清洗干净,加水以常规方式煎为药剂,冷却后以2500毫升为一剂封袋装存。
用法用量:换药前使用本发明的水剂反复冲洗,清洁患处。
实施例3:
取三丫苦15g,椿皮16g,火炭母12g,积雪草16g,狼毒15g,白鹤灵芝16g,血竭16g,山大颜18g,紫玉簪19g,鸡血藤19g,三棱15g,干漆16g,水红花子19g,喜树果16g,急性子19g,郁金19g,冬凌草16g,片姜黄15g,红粉16g,炉甘石15g,枫香脂16g,将上述原料清洗干净,加水以常规方式煎为药剂,冷却后以2500毫升为一剂封袋装存。
用法用量:换药前使用本发明的水剂反复冲洗,清洁患处。
以上所述是本发明的优选实施方式,应当指出,对于本技术领域的普通技术人员来说,在不脱离本发明原理的前提下,还可以做出若干改进和润饰,这些改进和润饰也视为本发明的保护范围。
Claims (3)
1.一种用于慢性宫颈炎的清洗用中药,其特征为,由以下重量份数的中药制成:三丫苦11~15g,椿皮10~16g,火炭母9~12g,积雪草9~16g,狼毒9~15g,白鹤灵芝10~16g,血竭9~16g,山大颜12~18g,紫玉簪10~19g,鸡血藤12~19g,三棱10~15g,干漆10~16g,水红花子12~19g,喜树果9~16g,急性子11~19g,郁金13~19g,冬凌草11~16g,片姜黄10~15g,红粉10~16g,炉甘石9~15g,枫香脂9~16g。
2.根据权利要求1所述的用于慢性宫颈炎的清洗用中药,其特征为,由以下重量份数的中药制成:三丫苦11g,椿皮10g,火炭母9g,积雪草9g,狼毒9g,白鹤灵芝10g,血竭9g,山大颜12g,紫玉簪10g,鸡血藤12g,三棱10g,干漆10g,水红花子12g,喜树果9g,急性子11g,郁金13g,冬凌草11g,片姜黄10g,红粉10g,炉甘石9g,枫香脂9g。
3.根据权利要求1或2所述的用于慢性宫颈炎的清洗用中药,其特征在于:所述中药以常规方式煎为药剂,冷却后以2500毫升为一剂封袋装存。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510623938.3A CN105169263A (zh) | 2015-09-28 | 2015-09-28 | 一种用于慢性宫颈炎的清洗用中药 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510623938.3A CN105169263A (zh) | 2015-09-28 | 2015-09-28 | 一种用于慢性宫颈炎的清洗用中药 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN105169263A true CN105169263A (zh) | 2015-12-23 |
Family
ID=54892011
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201510623938.3A Pending CN105169263A (zh) | 2015-09-28 | 2015-09-28 | 一种用于慢性宫颈炎的清洗用中药 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN105169263A (zh) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105327008A (zh) * | 2015-11-10 | 2016-02-17 | 李彦霞 | 一种治疗妇科炎症的中药 |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102198207A (zh) * | 2011-06-03 | 2011-09-28 | 田冰 | 一种治疗妇科阴道炎、宫颈炎的外用洗液 |
CN102228651A (zh) * | 2011-06-23 | 2011-11-02 | 张海 | 一种治疗妇科炎症的中药组合物及其制备方法 |
CN103393962A (zh) * | 2013-07-29 | 2013-11-20 | 济南伟传信息技术有限公司 | 一种治疗花斑癣的外用中药 |
CN104906541A (zh) * | 2015-06-12 | 2015-09-16 | 马志刚 | 一种烧伤护理用药膏 |
-
2015
- 2015-09-28 CN CN201510623938.3A patent/CN105169263A/zh active Pending
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102198207A (zh) * | 2011-06-03 | 2011-09-28 | 田冰 | 一种治疗妇科阴道炎、宫颈炎的外用洗液 |
CN102228651A (zh) * | 2011-06-23 | 2011-11-02 | 张海 | 一种治疗妇科炎症的中药组合物及其制备方法 |
CN103393962A (zh) * | 2013-07-29 | 2013-11-20 | 济南伟传信息技术有限公司 | 一种治疗花斑癣的外用中药 |
CN104906541A (zh) * | 2015-06-12 | 2015-09-16 | 马志刚 | 一种烧伤护理用药膏 |
Non-Patent Citations (3)
Title |
---|
南京中医药大学: "《中药大辞典》", 31 March 2006, 上海科学技术出版社 * |
贾海荣等: "《妇科病诊治绝招》", 31 March 2011, 河北科学技术出版社 * |
陈可冀等: "《实用中西药临床治疗手册》", 31 October 1993, 中国医药科技出版社 * |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105327008A (zh) * | 2015-11-10 | 2016-02-17 | 李彦霞 | 一种治疗妇科炎症的中药 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101791378B (zh) | 一种用于伤口止血、抗炎、生肌的中药制剂 | |
CN103877429B (zh) | 一种治疗鼻窦炎的中药制剂及制备方法 | |
CN105213941A (zh) | 一种用于治疗小儿腹泻的中药组合物及其制备方法 | |
CN104906465A (zh) | 一种治疗妇女慢性盆腔炎的中药化瘀组合物及其制备方法 | |
CN103933393A (zh) | 一种治疗化脓性关节炎的中药及制备方法 | |
CN105169263A (zh) | 一种用于慢性宫颈炎的清洗用中药 | |
CN100450537C (zh) | 一种治疗前列腺增生的中药制剂 | |
CN105617275A (zh) | 一种用于治疗急性膀胱炎的中药制剂及制备方法 | |
CN105106774B (zh) | 一种用于会阴护理的中药护理包及其制备方法和中药组合物 | |
CN105232849A (zh) | 一种治疗烧伤的膏药 | |
CN104840838A (zh) | 一种治疗骨科扭挫伤的中药膏剂 | |
CN103550528A (zh) | 一种治疗胃阴不足型慢性胃炎的中药制剂及制备方法 | |
CN103800890B (zh) | 一种治疗月经失调的药物及制备方法 | |
CN108186864A (zh) | 一种治疗痤疮的中药 | |
CN105232661A (zh) | 一种治疗乳腺炎的中药组合物及其制备方法 | |
CN105535674A (zh) | 用于治疗慢性宫颈炎的药物 | |
CN105998781A (zh) | 一种治疗急性胃肠炎的药物组合物 | |
CN106362084B (zh) | 一种预防妇科疾病的侗医药 | |
CN116509969A (zh) | 一种治疗母牛临床型乳房炎的中药组合物及应用 | |
CN104491712A (zh) | 一种治疗肝癌的中药配方及其制备方法 | |
CN104689249A (zh) | 一种用于护理治疗气血两虚型烧伤的药物及制备方法 | |
CN104436043A (zh) | 一种治疗疮疡阳证的止痛消炎药膏及其制备方法 | |
CN104435888A (zh) | 一种治疗扁平疣的药物及其制备方法 | |
CN110742955A (zh) | 一种治疗腰痛病症的中药组合物 | |
CN111789900A (zh) | 二合一妇科清宫排毒养血中药 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20151223 |
|
RJ01 | Rejection of invention patent application after publication |